Literature DB >> 28120006

[Overweight and obesity are risk factors for development of cardiotoxicity from anthracyclines or sequential administration of anthracyclines and trastuzumab].

Martin Wilhelm1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28120006     DOI： 10.1007/s00066-017-1098-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trials.

Authors:  Sylvain Ladoire; Cecile Dalban; Henri Roché; Marc Spielmann; Pierre Fumoleau; Christelle Levy; Anne Laure Martin; Fiona Ecarnot; Frank Bonnetain; François Ghiringhelli
Journal:  Eur J Cancer       Date:  2013-12-04       Impact factor: 9.162

Review 2.  Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity.

Authors:  Marzia Lotrionte; Giuseppe Biondi-Zoccai; Antonio Abbate; Gaetano Lanzetta; Fabrizio D'Ascenzo; Vincenzo Malavasi; Mariangela Peruzzi; Giacomo Frati; Giovanni Palazzoni
Journal:  Am J Cardiol       Date:  2013-09-25       Impact factor: 2.778

Review 3.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

Review 4.  Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Charles Guenancia; Annick Lefebvre; Daniela Cardinale; Anthony F Yu; Sylvain Ladoire; François Ghiringhelli; Marianne Zeller; Luc Rochette; Yves Cottin; Catherine Vergely
Journal:  J Clin Oncol       Date:  2016-07-25       Impact factor: 44.544

Review 5.  Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.

Authors:  Michel G Khouri; Pamela S Douglas; John R Mackey; Miguel Martin; Jessica M Scott; Marielle Scherrer-Crosbie; Lee W Jones
Journal:  Circulation       Date:  2012-12-04       Impact factor: 29.690

6.  2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Authors:  Jose Luis Zamorano; Patrizio Lancellotti; Daniel Rodriguez Muñoz; Victor Aboyans; Riccardo Asteggiano; Maurizio Galderisi; Gilbert Habib; Daniel J Lenihan; Gregory Y H Lip; Alexander R Lyon; Teresa Lopez Fernandez; Dania Mohty; Massimo F Piepoli; Juan Tamargo; Adam Torbicki; Thomas M Suter
Journal:  Eur Heart J       Date:  2016-08-26       Impact factor: 29.983
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.